C COMPREHENSIVE CELL SOLUTIONS Trademark

Trademark Overview


On Wednesday, December 6, 2017, a trademark application was filed for C COMPREHENSIVE CELL SOLUTIONS with the United States Patent and Trademark Office. The USPTO has given the C COMPREHENSIVE CELL SOLUTIONS trademark a serial number of 87710789. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, April 18, 2025. This trademark is owned by New York Blood Center, Inc.. The C COMPREHENSIVE CELL SOLUTIONS trademark is filed in the Treatment & Processing of Materials Services, Pharmaceutical Products, Advertising, Business and Retail Services, Transportation & Storage Services, Computer & Software Services & Scientific Services, and Medical & Beauty Services & Agricultural Services categories with the following description:

Services to support and manage transfusion medicine, regenerative medicine and cellular-therapy related research and clinical programs from discovery through development and to the clinic, namely, cryopreservation of human cells

Services to support and manage transfusion medicine, regenerative medicine and cellular-therapy related research and clinical programs from discovery through development and to the clinic, namely, storage of blood and stem cells

Products to support and manage transfusion medicine, regenerative medicine and cellular-therapy related research and clinical programs from discovery through development and to the clinic, namely, blood plasma, blood for medical purposes, blood products for medical and clinical trial use, antibody positive plasma, phenotyped red cell units, monoclonal antibodies to RBC antigens, cord blood; mononuclear cells, progenitor cells, antibody preparations for use in medical clinical trials, research and medical purposes

Services to support and manage transfusion medicine, regenerative medicine and cellular-therapy related research and clinical programs from discovery through development and to the clinic, namely, providing independent review of clinical trials for business purposes

Services to support and manage transfusion medicine, regenerative medicine and cellular-therapy related research and clinical programs from discovery through development and to the clinic, namely, tissue bank services; cell processing services for use by others; stem cell storage; collection and preservation of human blood, apheresis, red blood cells, plasma and bone marrow

Services to support and manage transfusion medicine, regenerative medicine and cellular-therapy related research and clinical programs from discovery through development and to the clinic, namely, medical laboratory, pharmaceutical research services and pharmaceutical clinical trials for others

General Information


Serial Number87710789
Word MarkC COMPREHENSIVE CELL SOLUTIONS
Filing DateWednesday, December 6, 2017
Status710 - CANCELLED - SECTION 8
Status DateFriday, April 18, 2025
Registration Number5573697
Registration DateTuesday, October 2, 2018
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, July 17, 2018

Trademark Statements


Goods and ServicesServices to support and manage transfusion medicine, regenerative medicine and cellular-therapy related research and clinical programs from discovery through development and to the clinic, namely, cryopreservation of human cells
Description of MarkThe mark consists of the terms "COMPREHENSIVE CELL SOLUTIONS" in dark blue text with gray shadowing, positioned to the right of a stylized letter "C". The stylized letter "C" is divided into four segments, changing from light blue to dark blue from top to bottom. Solid bubbles surround the "C" also in the same light blue and dark blue radiating from each segment.
Goods and ServicesServices to support and manage transfusion medicine, regenerative medicine and cellular-therapy related research and clinical programs from discovery through development and to the clinic, namely, storage of blood and stem cells
Goods and ServicesProducts to support and manage transfusion medicine, regenerative medicine and cellular-therapy related research and clinical programs from discovery through development and to the clinic, namely, blood plasma, blood for medical purposes, blood products for medical and clinical trial use, antibody positive plasma, phenotyped red cell units, monoclonal antibodies to RBC antigens, cord blood; mononuclear cells, progenitor cells, antibody preparations for use in medical clinical trials, research and medical purposes
Indication of Colors claimedThe color(s) light blue, dark blue and gray is/are claimed as a feature of the mark.
Goods and ServicesServices to support and manage transfusion medicine, regenerative medicine and cellular-therapy related research and clinical programs from discovery through development and to the clinic, namely, providing independent review of clinical trials for business purposes
Goods and ServicesServices to support and manage transfusion medicine, regenerative medicine and cellular-therapy related research and clinical programs from discovery through development and to the clinic, namely, tissue bank services; cell processing services for use by others; stem cell storage; collection and preservation of human blood, apheresis, red blood cells, plasma and bone marrow
NOT AVAILABLE"COMPREHENSIVE CELL SOLUTIONS"
Goods and ServicesServices to support and manage transfusion medicine, regenerative medicine and cellular-therapy related research and clinical programs from discovery through development and to the clinic, namely, medical laboratory, pharmaceutical research services and pharmaceutical clinical trials for others

Classification Information


International Class040 - Treatment of materials.
US Class Codes100, 103, 106
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, April 18, 2025
Primary Code040
First Use Anywhere DateMonday, November 14, 2016
First Use In Commerce DateMonday, November 14, 2016

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, April 18, 2025
Primary Code005
First Use Anywhere DateMonday, January 23, 2017
First Use In Commerce DateMonday, January 23, 2017

International Class035 - Advertising; business management; business administration; office functions.
US Class Codes100, 101, 102
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, April 18, 2025
Primary Code035
First Use Anywhere DateSaturday, October 1, 2016
First Use In Commerce DateSaturday, October 1, 2016

International Class039 - Transport; packaging and storage of goods; travel arrangement.
US Class Codes100, 105
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, April 18, 2025
Primary Code039
First Use Anywhere DateMonday, November 14, 2016
First Use In Commerce DateMonday, November 14, 2016

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, April 18, 2025
Primary Code042
First Use Anywhere DateMonday, October 31, 2016
First Use In Commerce DateMonday, October 31, 2016

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, April 18, 2025
Primary Code044
First Use Anywhere DateMonday, November 14, 2016
First Use In Commerce DateMonday, November 14, 2016

Trademark Owner History


Party NameNew York Blood Center, Inc.
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressNew York, NY 10065

Party NameNew York Blood Center, Inc.
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressNew York, NY 10065

Party NameNew York Blood Center, Inc.
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressNew York, NY 10065

Trademark Events


Event DateEvent Description
Saturday, December 9, 2017NEW APPLICATION ENTERED
Sunday, December 17, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, December 19, 2017NOTICE OF DESIGN SEARCH CODE E-MAILED
Tuesday, March 13, 2018ASSIGNED TO EXAMINER
Thursday, March 15, 2018PREVIOUS ALLOWANCE COUNT WITHDRAWN
Thursday, March 15, 2018APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, March 20, 2018PRIORITY ACTION WRITTEN
Tuesday, March 20, 2018PRIORITY ACTION E-MAILED
Tuesday, March 20, 2018NOTIFICATION OF PRIORITY ACTION E-MAILED
Tuesday, May 29, 2018TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, May 29, 2018CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, May 29, 2018TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, June 27, 2018NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, July 17, 2018PUBLISHED FOR OPPOSITION
Tuesday, July 17, 2018OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 2, 2018REGISTERED-PRINCIPAL REGISTER
Monday, October 2, 2023COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Friday, December 6, 2024TEAS CHANGE OF OWNER ADDRESS RECEIVED
Friday, December 6, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, December 6, 2024APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Friday, December 6, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, June 4, 2018APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, December 6, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, April 18, 2025CANCELLED SEC. 8 (6-YR)